Close
 Indian J Med Microbiol  
 

Figure 4 (A-D): DWI at baseline (A) and post-treatment (B), and ADC maps at baseline (C) and post-treatment (D) of a 68-year-old man with HCC (arrows). ADC showed 55.1% increase after 2 weeks of tyrosine kinase inhibitor therapy

Figure 4 (A-D): DWI at baseline (A) and post-treatment (B), and ADC maps at baseline (C) and post-treatment (D) of a 68-year-old man with HCC (arrows). ADC showed 55.1% increase after 2 weeks of tyrosine kinase inhibitor therapy